Breaking News Headlines Today | Ground News

See every side of every news story

Elevation Oncology image

News from Elevation Oncology

Stay current with all the latest and breaking news from Elevation Oncology. Compare headlines and media bias behind news outlets on stories breaking today.

In total, 3 have been published by Elevation Oncology which Ground News has aggregated in the past 3 months.

The Ground News media bias check for Elevation Oncology is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

Is Elevation Oncology credible or reliable? Our Factuality score answers both of those questions. When it comes to Elevation Oncology, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about Elevation Oncology

Where is Elevation Oncology located?Elevation Oncology's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Elevation Oncology News

Concentra to Acquire Elevation in Bid to Eliminate Another Biotech ‘Zombie’

United States · United States

Concentra to Acquire Elevation in Bid to Eliminate Another Biotech ‘Zombie’

100% Center coverage: 1 sources

The offer is the latest in a series of deals by Concentra, an entity controlled by Tang Capital Partners, to buy struggling biotechs and shut them down.See the Story

Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates - Elevation Oncology

Boston, Massachusetts · Boston

Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates - Elevation Oncology

- Presented preclinical data for potentially differentiated HER3 ADC, EO-1022, at AACR Annual Meeting -- -- Expects to file IND application for EO-1022 in 2026 -- -- Cash runway into 2H 2026 --...Read Article

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research ...

United States · United States

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research ...

100% Center coverage: 1 sources

– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep and durable responses in hard-to-treat solid tumor indications See the Story

You've scrolled to the bottom of the feed, there are no more stories.